Empaglinide 25/5 mg (Empagliflozin, Linagliptin)
Empagliflozin 25mg · Linagliptin 5mg
Tablet · Prescription medication · Combination
Aju Pharmaceuticals Co., Ltd.
MFDS item code 202600399 · Approved 2026.02.12
Improvement of glycemic control in patients with type 2 diabetes mellitus
This medication is used to assist in the dietary and exercise regimen to enhance blood sugar control in patients with type 2 diabetes. In particular, it effectively aids blood sugar management by combining empagliflozin and linagliptin. This treatment contributes to controlling blood sugar levels, reducing the risk of complications and improving the health of the patient.
The recommended starting dose of this drug is empagliflozin 10 mg/linagliptin 5 mg once daily. For patients who tolerate empagliflozin 10 mg/linagliptin 5 mg and require additional glycemic control, the dose of this drug may be increased to 25/5 mg once daily. Patients switching to this drug from concomitant therapy with empagliflozin and linagliptin should take the same doses they were previously taking. This drug may be taken with or without food. Swallow the tablet whole. If you miss a dose of this drug, take it as soon as you remember. However, if the next dose is due within 12 hours, skip the missed dose and take the next dose at the usual time. Do not take a double dose in one day. This drug is not recommended to improve glycemic control in patients with an estimated glomerular filtration rate (eGFR) below 45 ml/min/1.73m2. No dose adjustment is required for patients with an estimated glomerular filtration rate of 45 ml/min/1.73m2 or higher. No dose adjustment is required in patients with mild or moderate hepatic impairment. Use of this drug is not recommended in patients with severe hepatic impairment, as it has not been studied in this population. No dose adjustment based on age is required. In patients 75 years of age or older, renal function and the risk of volume depletion should be considered.
This medication contains two components, empagliflozin and linagliptin, and is primarily used to assist in blood sugar control in patients with type 2 diabetes. This medication should not be used in patients allergic to empagliflozin or linagliptin, or any other components present in this drug. Additionally, it should not be administered to patients with type 1 diabetes, diabetic ketoacidosis, or those undergoing dialysis treatment. Patients with impaired kidney function may experience reduced effectiveness of this medication; thus, regular kidney function tests should be conducted before and during treatment. There is limited experience with this medication in patients with heart failure, so it should be used cautiously, and if any acute pancreatitis symptoms arise, the medication should be discontinued immediately and medical advice sought. While taking this medication, there may be symptoms of pancreatitis, such as persistent and severe abdominal pain; caution is advised, and if any blistering on the skin or symptoms similar to pemphigus appear, the medication should be stopped immediately. The most common side effect reported is urinary tract infection, and adverse effects such as hypoglycemia, pancreatitis, and hypersensitivity reactions have also been noted. Caution is required, especially when used with other blood sugar-lowering agents like insulin or sulfonylureas, as the risk of hypoglycemia increases. This medication may cause fluid loss; thus, it should be used carefully in patients with low blood pressure or cardiovascular disease, as well as in elderly patients. In cases of dehydration, the medication may need to be temporarily discontinued. Moreover, this drug can increase the risk of genital fungal infections, so appropriate treatment is necessary should infection symptoms occur. It is recommended to avoid using this medication during pregnancy and breastfeeding, and its safety and efficacy have not been established in children under 18 years old. In cases of overdose, there is no specific antidote, so appropriate treatment should be conducted based on symptoms, and this medication should be kept out of reach of children. Lastly, caution is advised when driving or operating machinery due to the risk of hypoglycemia, especially when taken alongside insulin or sulfonylureas.
Urinary tract infection, vulvovaginal candidiasis, vulvitis, balanitis, genital infection, hypersensitivity, angioedema, urticaria, hypoglycemia, thirst, ketoacidosis, cough, constipation, pancreatitis, oral ulcer formation, pruritus, rash, vesicular pemphigoid, rhabdomyolysis, blood volume depletion, increased urination, urinary difficulty, interstitial nephritis, increased amylase, increased lipase, increased hematocrit, increased serum lipids, increased blood creatinine, decreased glomerular filtration rate, epigastric pain, enterocolitis, bowel obstruction, gastroenteritis, shingles, cystitis, acute pyelonephritis, bronchitis, vestibular neuronitis, sepsis, pneumonia, decreased appetite, dehydration, hyperglycemia, cerebral infarction, speech disturbances, Alzheimer's dementia, chest pain, fever, facial edema, fatigue, death, chronic obstructive pulmonary disease, asthma, diabetic foot, skin lesions, liver metastasis, acute leukemia, basal cell carcinoma, non-small cell lung cancer, malignant pericardial effusion, gastric cancer, rectal cancer, pancreatic cancer, meniscus injury, pneumoconiosis, congestive heart failure, angina pectoris, acute myocardial infarction, unstable angina, cardiac arrest, diabetic retinopathy, acute kidney injury, end-stage renal disease, acute cholangitis, acute cholecystitis, cholangitis, dizziness, kidney transplant failure, abdominal pain, gastrointestinal disorder, irritable bowel syndrome, burning mouth syndrome, colitis, abdominal discomfort, dysphagia, gastric ulcer, gum bleeding, tooth loss, hemorrhoids, lower abdominal pain, diarrhea, vomiting, gastritis, leukoplakia, rhinitis, soft tissue infection, pharyngitis, scrub typhus, periodontitis, tonsillitis, laryngitis, viral upper respiratory infection, decreased appetite, hypercholesterolemia, inadequate diabetes control, malnutrition, hyponatremia, headache, drowsiness, chest discomfort, asthenia, epistaxis, oropharyngeal pain, voice disturbances, allergic rhinitis, exertional dyspnea, wet cough, arthralgia, osteoporosis, arthropathy, musculoskeletal discomfort, myositis, myalgia, soft tissue mass, postmenopausal osteoporosis, rotator cuff syndrome, increased triglycerides in blood, increased urinary albumin/creatinine ratio, positive urinary leukocytes, decreased hemoglobin, increased potassium in blood, increased creatinine in blood, increased blood creatine phosphokinase, androgenetic alopecia, hyperhidrosis, hair loss, dermatitis, anxiety, insomnia, depression, hypertension, benign prostatic hyperplasia, acute pyelonephritis, appendiceal abscess, appendicitis, meningitis, chronic otitis media, peritonsillar abscess, pulmonary tuberculosis, subcutaneous abscess, tubo-ovarian abscess, vestibular neuritis, intracranial aneurysm, vascular stent stenosis, vascular stent thrombosis, ureterolithiasis, cervicitis, hyponatremia, diabetes mellitus, lumbar pain, pathological myopia, retinal detachment, retinal vein occlusion, retinoschisis, sternum fracture, Prinzmetal angina, deep vein thrombosis, autoimmune hepatitis, hearing loss, otalgia, postural dizziness, lymphadenopathy, hypothyroidism, thyroid nodule, vulvar pruritus, genital pruritus, dyslipidemia, dry eyes, dyspnea, unstable angina, insomnia
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air or humidity, so it is important to store it in a tightly sealed container. The storage temperature should be maintained at room temperature between 1 degree and 30 degrees Celsius, avoiding excessively hot or cold environments.
Pale pink round film-coated tablet
30 tablets/bottle, 30 tablets/box [10 tablets/Alu-Alu*3]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Empagliflozin 25mg · Linagliptin 5mg
Tablet · Prescription medication · Combination
Aju Pharmaceuticals Co., Ltd.
CombinationEmpagliflozin 10mg · Linagliptin 5mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 25mg · Linagliptin 5mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 25mg · Linagliptin 5mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
CombinationEmpagliflozin 10mg · Linagliptin 5mg
Tablet · Prescription medication · Combination
Dongkoo Bio Pharmaceutical Co., Ltd.
CombinationEmpagliflozin 25mg · Linagliptin 5mg
Tablet · Prescription medication · Combination
Boryung Pharmaceutical Co., Ltd.
CombinationEmpagliflozin 10mg · Linagliptin 5mg
Tablet · Prescription medication · Combination
Boryung Pharmaceutical Co., Ltd.
Empagliflozin 25mg · Linagliptin 5mg
Tablet · Prescription medication · Combination
Daewon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.